Clinical Trial Update: SER100 in Isolated Systolic Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SER100 for isolated systolic hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Isolated Systolic Hypertension

Drugs mentioned

• SER100

Snippet

Sponsor: Serodus AS | Conditions: Isolated Systolic Hypertension | Phase 2 | Status: COMPLETED